{"id":"W4319660730","doi":"10.1016/s0140-6736(22)02406-0","title":"An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"Grifols; University of Toronto; Alnylam Pharmaceuticals; BioCryst; Regeneron Pharmaceuticals; CSL Behring; Pfizer","keywords":"Hereditary angioedema; Medicine; Placebo; Clinical endpoint; Angioedema; Crossover study; Pharmacokinetics; Clinical trial; Internal medicine; Pharmacodynamics; Randomized controlled trial; Dermatology; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001416212,0.002442678,0.004578523,0.0005143451,0.0004744233,0.001164427,0.00123449,0.003236918,0.009304499],"category_scores_gemma":[0.001745404,0.0008219938,0.002098477,0.0004598838,0.001303628,0.001258458,0.0004133742,0.00341661,0.001347799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007531629,"about_ca_system_score_gemma":0.0008670883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001449024,"about_ca_topic_score_gemma":0.00238221,"domain_scores_codex":[0.9993936,0.0003016453,0.00003041978,0.0001143005,0.00004557001,0.0001145006],"domain_scores_gemma":[0.999274,0.0002845534,0.0001070205,0.00006173414,0.00004364463,0.0002292016],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9859869,0.002878494,0.000175325,0.0007355744,0.0007602493,0.00004818169,0.0000375754,0.0001161509,0.001279219,0.0001105749,0.000639193,0.007232646],"study_design_scores_gemma":[0.9868156,0.01213495,0.0004087978,0.00001481173,0.0001579205,0.00001714481,0.000008164662,0.00008358094,0.00008414831,0.00006089608,0.0002077668,0.000006199487],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742484,0.01170289,0.001392568,0.001216098,0.001597054,0.004486834,0.001798614,0.0002605009,0.003297103],"genre_scores_gemma":[0.9667949,0.008701194,0.002625186,0.002742196,0.001118712,0.007374323,0.001820745,0.00006980888,0.008752903],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009304499,"threshold_uncertainty_score":0.03112662,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1007508725685694,"score_gpt":0.3749197365572001,"score_spread":0.2741688639886307,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}